Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Oppenheimer analyst Kostas Biliouris reiterates Sarepta Therapeutics with a Outperform and maintains $37 price target.